Thursday, 3 April 2025 | 15:10 - 15:55

ROUNDTABLE DISCUSSIONS. Table 3: Balancing Internal R&D Investments and Resources with External Collaborations

Location:VIA BaselTrack:29th European Biopharma Project Program and Portfolio Management

In this roundtable discussion, participants will explore the complexities of balancing internal R&D investments with external collaborations. Attendees will engage in an open dialogue on how to evaluate and prioritize resources across both internal projects and external opportunities. The session will focus on strategies for optimizing resource allocation to ensure both internal innovation and successful external partnerships. Key discussion points:

• Analytical frameworks for evaluating R&D investments and resource allocation.

• Strategies and tools for balancing internal project investments with external collaborations.

• Best practices for prioritizing resources between competing internal and external projects.

Participants are encouraged to share their own experiences and challenges, benchmark strategies, and collaborate on solutions for more effective resource planning in R&D environments.

1 speaker

  • Piet Theisohn

    Former Vice President, Clinical Development & Operations

    Bayer

Location image

Session location VIA Basel